Eupraxia Pharmaceuticals Inc. (EPRX) vs Sagimet Biosciences Inc. (SGMT)
Eupraxia Pharmaceuticals Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and Sagimet Biosciences Inc. are of similar size ($561.1M and $537.8M). Across the 10 metrics below, Sagimet Biosciences Inc. leads on 7 and Eupraxia Pharmaceuticals Inc. on 3.
Valuation
Profitability
| Metric | EPRX | SGMT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (117.82%) | (24.37%) | (57.72%) |
| Return on assets | (64.44%) | (23.49%) | (49.22%) |
| Return on invested capital | 0.00% | (205.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack